That AI in drug discovery market The report gives the neatly explained structure of the market including all the individual business related data of the market on a worldwide scale. The total amount of data identified with the market is collected from different sources and this main part of the data is compiled by a collection of authorities through the use of different methodological procedures and logical tools, e.g. B. SWOT, orchestrates, processes and addresses analysis to produce a complete arrangement of an exchange based examination with respect to the Ai In Drug Discovery Market.

“According to the research report published by Polaris Market Research, the global Artificial Intelligence in Drug Discovery market size is expected to reach US$5,558.0 million by 2029, growing at a CAGR of 33.90% over the forecast period.”

Download a sample copy of the report to understand the structure of the full report (including full TOC, table and figures) @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample

Prominent key players – covered in the report:

• Atomwise
• Benevolent AI
• mountain health
• BIOAGE
• BioSymetrics
• cloud pharma
• Cyclica
• deep genomics
• deep mind
• envisagenics
• EURETOS
• Excientia
• GNS Healthcare
• IBM Corporation
• insilico medicine
• instro
• NuMedii
• Number
• NVIDIA Corporation
• OWKIN Inc.
• Ari Pharmaceuticals Inc.
• Verge genomics
• XtalPi Inc.

(customization available)

Report highlights?

The report provides a 360 degree overview of the market, emphasizing key factors driving, repelling, challenging and creating opportunities in the market in the forecasted duration. The report also lists the names of the major players operating in the market and the strategies they employ to earn the lion’s share of the market. It also offers interesting insights into the market, current Ai In Drug Discovery market trends, and key industry developments of the market. The report also covers the table of…